Marijuana specialist Sara Gullickson was just recently called CEO of Item 9 Labs Corp, an Arizona based business concentrated on the advancement of cannabis-related technology and products. Gullickson’s brand-new position with Item 9 Labs makes her the first female CEO of a U.S. openly traded marijuana company. Gullickson formerly acted as CEO and Creator of Dispensary Permits, a cannabis consulting company, which was gotten by Product 9 Labs on Nov 26, 2018.
” From the start, Item 9 Labs valued my industry understanding and almost years of experience. It was clear we share the exact same company culture and brand identity rooted in health and wellness. I am thrilled to be at the executive forefront and cultivate a company that will grow with the burgeoning global cannabis market,”
mentioned Gullickson. The position is a milestone for the monetary sector where females hold just 10% of magnate positions at publicly traded companies in the S&P’s Composite 1500. Within the marijuana market, only 27% of females hold C-suite positions, which is somewhat higher than the 23% nationwide average for women across all U.S. businesses.
” Our Company has actually seen sped up growth in the past year and we understood we required somebody with Sara’s experience and industry instinct to take us to the next level. With Sara’s global background and market foresight, Item 9 Labs is poised to turn into one of the preeminent leaders in shop and organic marijuana products accommodating the natural way of life market,” said Bryce Skalla, President of Item 9 Labs.